Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07562451 · ClinicalTrials.gov registry record · NA
Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
A NA study, sponsored by Emory University.
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07562451 is a NA study that has not yet begun recruiting, run by Emory University. The registered enrollment target is 25 participants.
The verdict
NCT07562451, a NA study, has not yet begun recruiting, sponsored by Emory University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate whether a 4-week music therapy (MT) intervention can reduce chronic pain and improve psychosocial outcomes in youth with sickle cell disease (SCD). The main questions it aims to answer are: * Does MT reduce pain intensity, frequency of pain episodes, and improve health-related quality of life (HRQoL)? * Does MT alter immune cell composition and gene expression in inflammatory pathways, as measured by single-cell RNA sequencing (scRNA-seq)? Researchers will compare participants randomized to music therapy versus a control condition to see if MT produces superior improvements in pain and psychosocial outcomes, and distinct molecular changes.
Interventions
- OTHER Standard of Care
- OTHER Music Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07562451
The ClinicalTrials.gov registry entry for NCT07562451 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07562451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07562451 about?
NCT07562451 is a clinical study titled "Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing". The goal of this clinical trial is to evaluate whether a 4-week music therapy (MT) intervention can reduce chronic pain and improve psychosocial outcomes in youth with sickle cell disease (SCD). The main questions it aims to answer are: * Does MT reduce pain intensity, frequency of pain episodes, ...
What is the current status of trial NCT07562451?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-07. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07562451?
The interventions under investigation include: Standard of Care (OTHER), Music Therapy (OTHER).
Who is sponsoring clinical trial NCT07562451?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.